109 related articles for article (PubMed ID: 378311)
1. Activity of prostacyclin, a stable analogue, 6 beta-PGI1 and 6-oxo-PGF1 alpha on canine isolated parietal cells [proceedings].
Soll AH; Whittle BJ
Br J Pharmacol; 1979 May; 66(1):97P-98P. PubMed ID: 378311
[No Abstract] [Full Text] [Related]
2. Effects of prostacyclin (PGI2), PGI1 and 6-oxo-PGF1alpha on the rat gastric mucosa [proceedings].
Boughton-Smith NK; Vane JR; Whittle BJ
Br J Pharmacol; 1978 Mar; 62(3):413P. PubMed ID: 346130
[No Abstract] [Full Text] [Related]
3. Effects of prostacyclin and a stable analogue, 6-beta-PGI1, on gastric acid secretion, mucosal blood flow, and blood pressure in conscious dogs.
Kauffman GL; Whittle BJ; Aures D; Vane JR; Grossman MI
Gastroenterology; 1979 Dec; 77(6):1301-6. PubMed ID: 387511
[TBL] [Abstract][Full Text] [Related]
4. Gastric antisecretory and cardiovascular actions of a stable 16-phenoxy prostacyclin analog in the dog.
Kauffman GL; Whittle BJ; Aures D; Grossman MI
Adv Prostaglandin Thromboxane Res; 1980; 8():1521-4. PubMed ID: 6990722
[No Abstract] [Full Text] [Related]
5. Prostacyclin analogues inhibit canine parietal cell activity and cyclic AMP formation.
Soll AH; Whittle BJ
Prostaglandins; 1981 Feb; 21(2):353-65. PubMed ID: 6261301
[TBL] [Abstract][Full Text] [Related]
6. [Effect of prostacyclin and 6-keto-PGFl alpha on coronary vascular resistance].
Boroian RG
Zh Eksp Klin Med; 1978; 18(4):40-4. PubMed ID: 360725
[No Abstract] [Full Text] [Related]
7. Effects of prostacyclin, 6-keto-PGF1 alpha PGF2 alpha and 15[S]15-methyl-PGF2 alpha on platelet aggregation in vitro.
Marmo E; Somma A; Ottavo R; Vairo G; Spaziante G; DiMezza F; Paone G
J Med; 1981; 12(2-3):97-108. PubMed ID: 7024451
[No Abstract] [Full Text] [Related]
8. Effect of different prostaglandin analogues on gastric acid secretion and mucosal blood flow in the dog: action on stimulated and resting mucosa.
Bálint GA; Sági I; Döbrönte Z; Varró V
Acta Med Hung; 1984; 41(2-3):149-55. PubMed ID: 6379594
[TBL] [Abstract][Full Text] [Related]
9. Actions of prostacyclin (PGI2) and its product, 6-oxo-PGF1alpha on the rat gastric mucosa in vivo and in vitro.
Whittle BJ; Boughton-Smith NK; Moncada S; Vane JR
Prostaglandins; 1978 Jun; 15(6):955-67. PubMed ID: 358297
[TBL] [Abstract][Full Text] [Related]
10. Specific inhibition by prostaglandins E2 and I2 of histamine-stimulated [14C]aminopyrine accumulation and cyclic adenosine monophosphate generation by isolated canine parietal cells.
Soll AH
J Clin Invest; 1980 May; 65(5):1222-9. PubMed ID: 6154063
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular research on PGI2, 6-keto-PGF1 alpha, PGF2 alpha, and 15(S)-15-methyl-PGF2 alpha.
Marmo E; Rossi F; Lampa E; Giordano L; Caputi AP; Vacca C; Ariello B; Rosatti F
Adv Prostaglandin Thromboxane Res; 1980; 7():701-9. PubMed ID: 6989197
[No Abstract] [Full Text] [Related]
12. The relative activity of prostacyclin (PGI2) and a stable analogue 6beta-PGI1 on the gastrointestinal and cardiovascular systems.
Whittle BJ; Boughton-Smith NK; Moncada S; Vane JR
J Pharm Pharmacol; 1978 Sep; 30(9):597-9. PubMed ID: 29109
[No Abstract] [Full Text] [Related]
13. Activation of guinea pig pulmonary adenylate cyclase by prostacyclin.
MacDermot J; Barnes PJ
Eur J Pharmacol; 1980 Oct; 67(4):419-25. PubMed ID: 6256175
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of acid secretion in isolated canine parietal cells by prostaglandins.
Skoglund ML; Nies AS; Gerber JG
J Pharmacol Exp Ther; 1982 Feb; 220(2):371-4. PubMed ID: 6799643
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the activities of prostacyclin and its stable analogs on the platelet aggregation and cardiovascular systems.
Kawasaki A; Ishii K; Wakitani K; Tsuboshima M
Adv Prostaglandin Thromboxane Res; 1980; 6():331-6. PubMed ID: 6992531
[No Abstract] [Full Text] [Related]
16. Interrelationships between the chemical structure of prostanoids and prostacyclins and their cytoprotective effects on the ethanol-induced gastric mucosal damage in rats (a comparative experimental study).
Székely I; Jávor T; Kovács G; Botár S; Morón F; Mózsik G
Acta Physiol Hung; 1984; 64(3-4):231-5. PubMed ID: 6397964
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationship (SAR) among prostacyclin (PGI2) analogues.
Kovács G; Székely I; Stadler I; Körmöczy P
Acta Physiol Hung; 1984; 64(3-4):225-30. PubMed ID: 6397963
[TBL] [Abstract][Full Text] [Related]
18. Action of prostacyclin (PGI2) and prostaglandin E2 (PGE2) on gastric secretion and mucosal blood flow in dogs.
Konturek SJ
Gastroenterology; 1980 Jul; 79(1):182-4. PubMed ID: 6991360
[No Abstract] [Full Text] [Related]
19. Prostaglandins as ocular hypotensive agents; development of an analogue for glaucoma treatment.
Stjernschantz J
Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():63-8. PubMed ID: 7732906
[No Abstract] [Full Text] [Related]
20. Dual actions of prostacyclin (PGI2) on the rat pregnant uterus.
Williams KI; El-Tahir KE; Marcinkiewicz E
Prostaglandins; 1979 May; 17(5):667-72. PubMed ID: 386426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
